Revenue

A new partnership aims to end pharmacy sticker shock by giving patients unprecedented control over prescription price, location, and availability.

Childhelp co-founder Sara O'Meara receives a lifetime achievement award, highlighting a new partnership and the ongoing fight to protect vulnerable children.

After securing its Nasdaq spot, TuHURA Biosciences shifts focus to its promising immuno-oncology pipeline, aiming to tackle cancer treatment resistance.

IoT specialist KORE Group agrees to a take-private acquisition by Searchlight and Abry, offering a massive 691% premium to shareholders.

Sustainable energy provider ThomasLloyd is merging with a SPAC to go public, aiming to solve the massive power crisis facing the booming AI industry.

Despite a dip in annual profits, Boralex commissions major UK and Canadian projects, showcasing financial resilience and commitment to its 2030 growth plan.

The natural gas producer raised its quarterly dividend by 11%, backed by strong earnings and a positive outlook despite volatile energy prices.

As Summit Midstream sets its Q4 earnings date, all eyes are on whether recent acquisitions and strong gas trends can solidify its financial recovery.

The organ transplant innovator's massive Q4 profit came from a tax rule, but it signals a major turning point and confidence in long-term profitability.

A key European panel recommends Dupixent for children with chronic hives, offering a potential first-of-its-kind targeted therapy for a difficult condition.

Fulgent Genetics reports revenue growth but faces a pivotal year with a major customer loss, betting its future on strategic acquisitions and a promising drug pipeline.

The consumer intelligence giant posts blockbuster results, achieves positive cash flow, and unveils a new AI-driven strategy for sustained market leadership.

MedX Health Corp. lands a crucial $2.7M in initial funding, aiming for $5M to expand its skin-screening tech into occupational health and manage debt.

Following mixed 2025 results, TransAlta will outline its strategic pivot to investors, focusing on renewables, data centers, and shareholder value.

Gogo's revenue doubled to $910M in 2025 after a major acquisition, but a Q4 loss and new tech rollout put its bold global strategy to the test.

A new AI-powered digital twin, backed by US government funding, promises to predict network failures and slash deployment costs for 5G/6G networks.

Treace Medical reports a Q4 revenue dip despite surgeon growth, revealing a strategic shift to lower-priced kits and a challenging 2026 outlook.

As BCE's CEO prepares for a key investor conference, the telecom giant balances a bold AI growth strategy against concerns over near-term profitability.

Endeavour Silver saw record 2025 revenue from new mines but posted a $119M loss due to financial instruments, high costs, and rising security risks in Mexico.

Startup World Cup's 'East Meets West' event positions Hawaii as a crucial hub for cross-Pacific innovation, with a $1M prize and Tim Draper in attendance.